Truist raised the firm’s price target on Leonardo DRS to $32 from $30 and keeps a Buy rating on the shares. The company’s “across the board beat”, guidance lift, and 1.2x book-to-bill were somewhat overshadowed by program-specific margin pressure, which drove down 2024 EBITDA margin guidance and what is seemingly implied revenue growth deceleration in the coming periods from the supply chain tailwinds that are now benefiting 2024, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DRS: